US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Palvella Therapeutics

112.37

-5.2400-4.46%

Post-market: 112.400.0300+0.03%18:09 EDT

Volume:218.59K

Turnover:25.06M

Market Cap:1.51B

PE:-31.84

High:119.35

Open:118.11

Low:111.76

Close:117.61

52wk High:151.18

52wk Low:18.23

Shares:13.44M

Float Shares:8.40M

Volume Ratio:0.84

T/O Rate:2.60%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-3.5291

EPS(LYR):-7.8322

ROE:-301.19%

ROA:-47.54%

PB:39.03

PE(LYR):-14.35

Loading ...

Overview Company News Filings

Palvella Therapeutics Announces Underwritten Common Stock Offering

Top Midday Gainers

MT Newswires Live

Assessing Palvella Therapeutics (PVLA) Valuation After Its Recent Share Price Surge

Simply Wall St.

Palvella Therapeutics 1.6M share Secondary priced at $125.00

BRIEF-Palvella Therapeutics Announces Pricing Of Upsized Public Offering

Palvella Therapeutics Inc - Expects $200 Mln Gross Proceeds From Offering

THOMSON REUTERS

Palvella Therapeutics Inc : Btig Raises Target Price to $215 From $192

THOMSON REUTERS

Palvella Therapeutics Inc : TD Cowen Raises Target Price to $267 From $190

THOMSON REUTERS

Palvella Therapeutics Inc - Commences Public Offering of $150.0 Mln of Shares of Its Common Stock

THOMSON REUTERS

Press Release: Palvella Therapeutics Announces Proposed Public Offering

Palvella Therapeutics price target raised to $209 from $143 at JonesResearch

Palvella Therapeutics Is Maintained at Buy by HC Wainwright & Co.

BUZZ-U.S. STOCKS ON THE MOVE-Henry Schein, Domino's Pizza, FactSet

Palvella Therapeutics Up Over 34%, on Track for Highest Close Since March 2023 -- Data Talk

Palvella Therapeutics price target raised to $255 from $200 at H.C. Wainwright

Palvella Therapeutics Inc. : H.c. Wainwright Raises Target Price to $255 From $200

THOMSON REUTERS

BUZZ-U.S. STOCKS ON THE MOVE-Advanced Micro Devices, Constellation Energy, NRG Energy

Mizuho Adjusts Price Target on Palvella Therapeutics to $250 From $205, Maintains Outperform Rating

MT Newswires Live

Palvella Therapeutics Shares Jump 23% Premarket After Co's Skin Disease Drug Meets Late-Stage Trial Goal

THOMSON REUTERS

BUZZ-Palvella jumps after rare disease treatment shows improvement in late-stage study

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/PVLA/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PVLA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PVLA\",,,,,undefined,":{"symbol":"PVLA","market":"US","secType":"STK","nameCN":"Palvella Therapeutics","latestPrice":112.37,"timestamp":1774641600000,"preClose":117.61,"halted":0,"volume":218587,"hourTrading":{"tag":"盘后","latestPrice":112.4,"preClose":112.37,"latestTime":"18:09 EDT","volume":13297,"amount":1505540.22,"timestamp":1774649350733,"change":0.03,"changeRate":0.000267,"amplitude":0.018955},"delay":0,"changeRate":-0.04455403452087403,"floatShares":8398100,"shares":13436500,"eps":-3.529122,"marketStatus":"Market Closed","change":-5.24,"latestTime":"03-27 16:00:00 EDT","open":118.11,"high":119.35,"low":111.755,"amount":25063745.00272,"amplitude":0.064578,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.529122,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1774857600000},"marketStatusCode":7,"adr":0,"listingDate":1435636800000,"exchange":"NASDAQ","adjPreClose":117.61,"preHourTrading":{"tag":"盘前","latestPrice":118.11,"preClose":117.61,"latestTime":"09:29 EDT","volume":392,"amount":46350.0408,"timestamp":1774618199999,"change":0.5,"changeRate":0.004251,"amplitude":0.008418},"postHourTrading":{"tag":"盘后","latestPrice":112.4,"preClose":112.37,"latestTime":"18:09 EDT","volume":13297,"amount":1505540.22,"timestamp":1774649350733,"change":0.03,"changeRate":0.000267,"amplitude":0.018955},"volumeRatio":0.8437459454576005,"impliedVol":0.7105,"impliedVolPercentile":0.494},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PVLA\",,,,,undefined,":{"symbol":"PVLA","floatShares":8398100,"roa":"-47.54%","roe":"-301.19%","lyrEps":-7.832217,"volumeRatio":0.8437459454576005,"shares":13436500,"dividePrice":0,"high":119.35,"amplitude":0.064578,"preClose":117.61,"low":111.755,"week52Low":18.225,"pbRate":"39.03","week52High":151.18,"institutionHeld":0,"latestPrice":112.37,"eps":-3.529122,"divideRate":0,"volume":218587,"delay":0,"ttmEps":-3.529122,"open":118.11,"prevYearClose":104.67,"prevWeekClose":112.5,"prevMonthClose":135.02,"prevQuarterClose":104.67,"fiveDayClose":112.5,"twentyDayClose":135.02,"sixtyDayClose":99.88,"earningDate":1774886400000,"earningTime":"盘前"},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PVLA\",params:#limit:5,,,undefined,":[{"date":"2026-03-31","symbol":"PVLA","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2025/12","expectedEps":-0.95,"defaultRemindTime":1774944000000,"name":null,"time":"Pre-Market","dateTimestamp":1774929600000,"actualEps":null},{"market":"US","date":"2025-11-11","symbol":"PVLA","fiscalQuarterEnding":"2025/09","expectedEps":-0.85,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1762837200000,"reportTimeType":"pre","actualEps":-1.03},{"market":"US","date":"2025-08-14","symbol":"PVLA","fiscalQuarterEnding":"2025/06","expectedEps":-0.78,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1755144000000,"reportTimeType":"pre","actualEps":-0.86},{"market":"US","date":"2025-05-15","symbol":"PVLA","fiscalQuarterEnding":"2025/03","expectedEps":-3.4,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1747281600000,"reportTimeType":"pre","actualEps":-0.74},{"market":"US","date":"2025-03-31","symbol":"PVLA","fiscalQuarterEnding":"2024/12","expectedEps":-0.39,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1743393600000,"reportTimeType":"pre","actualEps":4}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PVLA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PVLA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.25,"buy":0.75,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.75,"analysts":16,"updateTime":1767844800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PVLA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PVLA","date":"2026-03-27","current":-31.840781,"percent":0.047022,"low":-60.48704,"twenty":-32.06614,"median":-18.561811,"eighty":19.083855,"high":46.119317,"avg":-13.594266,"sd":25.070652,"marketCap":1580265588},"quantilePoints":[{"date":"2024-12-20","current":19.163371,"twenty":19.017062,"median":19.163371,"eighty":20.457893,"marketCap":135216749},{"date":"2024-12-27","current":19.083855,"twenty":18.842127,"median":19.083855,"eighty":19.659551,"marketCap":134655684},{"date":"2025-01-03","current":21.071757,"twenty":18.969352,"median":19.083855,"eighty":19.907642,"marketCap":148682317},{"date":"2025-01-10","current":22.216788,"twenty":19.083855,"median":19.083855,"eighty":21.987782,"marketCap":156761658},{"date":"2025-01-17","current":20.960435,"twenty":19.083855,"median":20.523096,"eighty":21.13537,"marketCap":147896826},{"date":"2025-01-24","current":19.863113,"twenty":19.083855,"median":20.650322,"eighty":21.071757,"marketCap":140154124},{"date":"2025-01-31","current":20.674177,"twenty":19.083855,"median":20.658273,"eighty":21.151273,"marketCap":145876991},{"date":"2025-02-07","current":24.729496,"twenty":19.083855,"median":20.674177,"eighty":22.089563,"marketCap":174491323},{"date":"2025-02-14","current":31.090781,"twenty":19.083855,"median":20.912725,"eighty":23.46519,"marketCap":219376551},{"date":"2025-02-21","current":30.565975,"twenty":19.147468,"median":20.992241,"eighty":24.783567,"marketCap":215673520},{"date":"2025-02-28","current":30.804523,"twenty":19.723165,"median":21.111515,"eighty":29.913943,"marketCap":217356716},{"date":"2025-03-07","current":39.042387,"twenty":20.066674,"median":21.469337,"eighty":30.728188,"marketCap":275483086},{"date":"2025-03-14","current":43.678174,"twenty":20.34657,"median":22.439433,"eighty":31.793703,"marketCap":308193196},{"date":"2025-03-21","current":44.751641,"twenty":20.49288,"median":23.46519,"eighty":33.810231,"marketCap":315767578},{"date":"2025-03-28","current":44.688028,"twenty":20.604203,"median":24.292158,"eighty":40.654974,"marketCap":315318726},{"date":"2025-04-04","current":-15.155991,"twenty":19.723165,"median":23.46519,"eighty":39.236406,"marketCap":264229553},{"date":"2025-04-11","current":-13.752893,"twenty":19.083855,"median":22.439433,"eighty":38.266311,"marketCap":239767934},{"date":"2025-04-17","current":-15.396161,"twenty":19.00752,"median":21.77945,"eighty":36.545583,"marketCap":268416676},{"date":"2025-04-25","current":-16.047148,"twenty":-12.608925,"median":21.151273,"eighty":34.239617,"marketCap":279765986},{"date":"2025-05-02","current":-15.493342,"twenty":-14.192783,"median":21.008144,"eighty":33.36176,"marketCap":270110923},{"date":"2025-05-09","current":-14.42287,"twenty":-14.682214,"median":20.912725,"eighty":33.091405,"marketCap":251448313},{"date":"2025-05-16","current":-10.548775,"twenty":-14.614161,"median":20.674177,"eighty":32.251716,"marketCap":243497378},{"date":"2025-05-23","current":-10.577479,"twenty":-14.552086,"median":20.64237,"eighty":31.796884,"marketCap":244159956},{"date":"2025-05-30","current":-11.868448,"twenty":-14.483678,"median":20.515145,"eighty":31.510626,"marketCap":273959378},{"date":"2025-06-06","current":-11.250599,"twenty":-14.245514,"median":19.990339,"eighty":31.090781,"marketCap":259697570},{"date":"2025-06-13","current":-12.65393,"twenty":-13.898957,"median":19.083855,"eighty":30.976278,"marketCap":292090669},{"date":"2025-06-20","current":-9.82332,"twenty":-13.773118,"median":19.083855,"eighty":30.785439,"marketCap":226751689},{"date":"2025-06-27","current":-9.876005,"twenty":-13.751337,"median":19.083855,"eighty":30.680478,"marketCap":227967812},{"date":"2025-07-03","current":-11.552339,"twenty":-13.745115,"median":18.829404,"eighty":30.565975,"marketCap":266662639},{"date":"2025-07-11","current":-12.902986,"twenty":-13.143371,"median":-9.82332,"eighty":30.216104,"marketCap":297839615},{"date":"2025-07-18","current":-14.957693,"twenty":-13.611836,"median":-10.196903,"eighty":29.977556,"marketCap":345268417},{"date":"2025-07-25","current":-18.501942,"twenty":-13.979479,"median":-10.548775,"eighty":29.89804,"marketCap":427080338},{"date":"2025-08-01","current":-17.520089,"twenty":-14.593892,"median":-10.570486,"eighty":26.844623,"marketCap":404416225},{"date":"2025-08-08","current":-18.703103,"twenty":-14.909501,"median":-10.577479,"eighty":25.683689,"marketCap":431723718},{"date":"2025-08-15","current":-17.957373,"twenty":-15.155991,"median":-10.795594,"eighty":24.999851,"marketCap":509666156},{"date":"2025-08-22","current":-19.99406,"twenty":-15.421442,"median":-10.987175,"eighty":24.729496,"marketCap":567471411},{"date":"2025-08-29","current":-19.990163,"twenty":-15.528887,"median":-11.165181,"eighty":23.854819,"marketCap":567360814},{"date":"2025-09-05","current":-21.096831,"twenty":-16.235493,"median":-11.305678,"eighty":23.549477,"marketCap":598770263},{"date":"2025-09-12","current":-22.776317,"twenty":-17.271569,"median":-11.413443,"eighty":23.46678,"marketCap":646437419},{"date":"2025-09-19","current":-23.006223,"twenty":-17.715742,"median":-11.554734,"eighty":23.433384,"marketCap":652962621},{"date":"2025-09-26","current":-22.480166,"twenty":-18.057474,"median":-11.868448,"eighty":22.814749,"marketCap":638032073},{"date":"2025-10-03","current":-24.405145,"twenty":-18.52589,"median":-11.961844,"eighty":22.305846,"marketCap":692666818},{"date":"2025-10-10","current":-27.312096,"twenty":-18.938434,"median":-12.127082,"eighty":22.115008,"marketCap":775171919},{"date":"2025-10-17","current":-28.500595,"twenty":-19.602341,"median":-12.457671,"eighty":21.593382,"marketCap":808903898},{"date":"2025-10-24","current":-27.783599,"twenty":-20.103168,"median":-12.65393,"eighty":21.227608,"marketCap":788554114},{"date":"2025-10-31","current":-30.558062,"twenty":-20.870432,"median":-12.719639,"eighty":21.154454,"marketCap":867298929},{"date":"2025-11-07","current":-30.639894,"twenty":-21.250362,"median":-12.96286,"eighty":21.08766,"marketCap":869621458},{"date":"2025-11-14","current":-28.915921,"twenty":-22.006325,"median":-13.231068,"eighty":21.033589,"marketCap":952837445},{"date":"2025-11-21","current":-32.881534,"twenty":-22.215189,"median":-13.745115,"eighty":20.998602,"marketCap":1083512294},{"date":"2025-11-28","current":-36.922579,"twenty":-22.816843,"median":-13.778174,"eighty":20.973157,"marketCap":1216672807},{"date":"2025-12-05","current":-33.693335,"twenty":-23.242364,"median":-14.278382,"eighty":20.931809,"marketCap":1110262762},{"date":"2025-12-12","current":-34.763763,"twenty":-24.512694,"median":-14.593892,"eighty":20.769596,"marketCap":1145535502},{"date":"2025-12-19","current":-34.569792,"twenty":-27.267674,"median":-14.831115,"eighty":20.674177,"marketCap":1139143797},{"date":"2025-12-26","current":-38.014559,"twenty":-27.693195,"median":-14.933597,"eighty":20.674177,"marketCap":1252655736},{"date":"2026-01-02","current":-37.597882,"twenty":-28.489684,"median":-15.118842,"eighty":20.670996,"marketCap":1238925408},{"date":"2026-01-09","current":-34.979285,"twenty":-28.647112,"median":-15.258978,"eighty":20.655092,"marketCap":1152637396},{"date":"2026-01-16","current":-37.350031,"twenty":-29.232399,"median":-15.408801,"eighty":20.639189,"marketCap":1230758230},{"date":"2026-01-23","current":-33.075504,"twenty":-29.325414,"median":-15.443563,"eighty":20.626467,"marketCap":1089903999},{"date":"2026-01-30","current":-29.418807,"twenty":-29.517639,"median":-15.528887,"eighty":20.515145,"marketCap":969408531},{"date":"2026-02-06","current":-27.453961,"twenty":-29.48062,"median":-16.091391,"eighty":20.403822,"marketCap":904662930},{"date":"2026-02-13","current":-29.461912,"twenty":-29.48062,"median":-17.007828,"eighty":20.117564,"marketCap":970828909},{"date":"2026-02-20","current":-29.573265,"twenty":-29.488024,"median":-17.242297,"eighty":19.914003,"marketCap":974498221},{"date":"2026-02-27","current":-60.48704,"twenty":-29.707799,"median":-17.512905,"eighty":19.303319,"marketCap":1993168926},{"date":"2026-03-06","current":-55.02714,"twenty":-30.090518,"median":-17.81704,"eighty":19.099758,"marketCap":1813254325},{"date":"2026-03-13","current":-55.699943,"twenty":-30.574428,"median":-17.963839,"eighty":19.083855,"marketCap":1835424534},{"date":"2026-03-20","current":-46.447881,"twenty":-31.137829,"median":-18.431476,"eighty":19.083855,"marketCap":1530550575},{"date":"2026-03-27","current":-47.956591,"twenty":-32.06614,"median":-18.561811,"eighty":19.083855,"marketCap":1580265588}],"updateTime":1774834159996},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PVLA\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2614375005","title":"Palvella Therapeutics Announces Underwritten Common Stock Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2614375005","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614375005?lang=en_us&edition=fundamental","pubTime":"2026-02-27 08:29","pubTimestamp":1772152168,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Palvella Therapeutics ( ($PVLA) ). On February 25, 2026, Palvella Therapeutics, Inc. entered into an underwriti...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/palvella-therapeutics-announces-underwritten-common-stock-offering?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/palvella-therapeutics-announces-underwritten-common-stock-offering?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PVLA","BK4139"],"gpt_icon":0},{"id":"2614020865","title":"Top Midday Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2614020865","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614020865?lang=en_us&edition=fundamental","pubTime":"2026-02-27 02:29","pubTimestamp":1772130551,"startTime":"0","endTime":"0","summary":"Enerflex  said late on Wednesday its preliminary 2026 outlook \"reflects steady demand across its business lines and geographic regions\" while reporting a swing to a Q4 net loss, and it signed a deal to divest the majority of its operations in the Asia Pacific region.Shares jumped 16% as intraday trading volume climbed to more than 436,000 from a daily average of about 447,000.Palvella Therapeutics  said late Wednesday it priced an upsized offering of 1.6 million shares at $125 each and granted underwriters an option to purchase up to 240,000 additional shares, targeting gross proceeds of about $200 million.Shares advanced 13% as intraday trading volume jumped to over 769,000 from a daily average of roughly 292,000.Novavax  shares rose 18% amid heavy trading on Thursday after the company swung to a profit in Q4, with revenue exceeding analysts' expectations.More than 16.9 million shares of the company traded intraday compared with a daily average of about 4.3 million.Price: 23.17, Chang","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","BK4179","BK4588","PVLA","BK4547","BK4568","EFXT","NVAX","BK4585"],"gpt_icon":0},{"id":"2614047617","title":"Assessing Palvella Therapeutics (PVLA) Valuation After Its Recent Share Price Surge","url":"https://stock-news.laohu8.com/highlight/detail?id=2614047617","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614047617?lang=en_us&edition=fundamental","pubTime":"2026-02-26 21:37","pubTimestamp":1772113051,"startTime":"0","endTime":"0","summary":"Why Palvella Therapeutics Has Caught Investor Attention\nRecent trading in Palvella Therapeutics (PVLA) has drawn attention after a sharp share price move, with the stock closing at US$128.60 and posting very large 1 year total returns.\nThat type of performance, together with reported annual revenue growth of 63.12% and net income growth of 54.52% on a net loss of US$32.37 million, is prompting investors to reassess how they view this clinical stage biopharmaceutical name.\nSee our latest...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-pvla/palvella-therapeutics/news/assessing-palvella-therapeutics-pvla-valuation-after-its-rec","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-pvla/palvella-therapeutics/news/assessing-palvella-therapeutics-pvla-valuation-after-its-rec","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["DCF","PVLA","BK4139"],"gpt_icon":0},{"id":"2614069328","title":"Palvella Therapeutics 1.6M share Secondary priced at $125.00","url":"https://stock-news.laohu8.com/highlight/detail?id=2614069328","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614069328?lang=en_us&edition=fundamental","pubTime":"2026-02-26 09:10","pubTimestamp":1772068234,"startTime":"0","endTime":"0","summary":"The deal size was increased to $200M from $150M and priced below last closing price of $128.60. TD Cowen, Cantor Fitzgerald, Stifel, Mizuho, LifeSc...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/palvella-therapeutics-1-6m-share-secondary-priced-at-125-00-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/palvella-therapeutics-1-6m-share-secondary-priced-at-125-00-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","PVLA"],"gpt_icon":0},{"id":"2614523066","title":"BRIEF-Palvella Therapeutics Announces Pricing Of Upsized Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2614523066","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614523066?lang=en_us&edition=fundamental","pubTime":"2026-02-26 08:59","pubTimestamp":1772067567,"startTime":"0","endTime":"0","summary":"BRIEF-Palvella Therapeutics Announces Pricing Of Upsized Public OfferingFeb 25 (Reuters) - Palvella Therapeutics Inc PVLA.O:PALVELLA THERAPEUTICS ANNOUNCES PRICING OF UPSIZED PUBLIC OFFERINGPALVELLA T","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260226:nTUA15SC1C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PVLA","BK4139"],"gpt_icon":0},{"id":"2614803066","title":"Palvella Therapeutics Inc - Expects $200 Mln Gross Proceeds From Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2614803066","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614803066?lang=en_us&edition=fundamental","pubTime":"2026-02-26 08:57","pubTimestamp":1772067420,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260226:nTUA15SC1C:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","PVLA"],"gpt_icon":0},{"id":"2614774947","title":"Palvella Therapeutics Inc : Btig Raises Target Price to $215 From $192","url":"https://stock-news.laohu8.com/highlight/detail?id=2614774947","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614774947?lang=en_us&edition=fundamental","pubTime":"2026-02-25 13:06","pubTimestamp":1771995975,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260225:nFWN3ZK17T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","PVLA"],"gpt_icon":0},{"id":"2614711257","title":"Palvella Therapeutics Inc : TD Cowen Raises Target Price to $267 From $190","url":"https://stock-news.laohu8.com/highlight/detail?id=2614711257","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614711257?lang=en_us&edition=fundamental","pubTime":"2026-02-25 12:32","pubTimestamp":1771993944,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260225:nFWN3ZK14R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PVLA","BK4139"],"gpt_icon":0},{"id":"2614728689","title":"Palvella Therapeutics Inc - Commences Public Offering of $150.0 Mln of Shares of Its Common Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2614728689","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614728689?lang=en_us&edition=fundamental","pubTime":"2026-02-25 05:05","pubTimestamp":1771967103,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260224:nTUA7W4FNM:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PVLA","BK4139"],"gpt_icon":0},{"id":"2614802728","title":"Press Release: Palvella Therapeutics Announces Proposed Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2614802728","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614802728?lang=en_us&edition=fundamental","pubTime":"2026-02-25 05:05","pubTimestamp":1771967100,"startTime":"0","endTime":"0","summary":"WAYNE, Pa., Feb. 24, 2026  -- Palvella Therapeutics, Inc.  , a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare skin diseases and vascular malformations for which there are no U.S. Food and Drug Administration -approved therapies, today announced that it has commenced an underwritten public offering of $150.0 million of shares of its common stock. In addition, Palvella expects to grant the underwriters a 30-day option to purchase up to an additional $22.5 million of shares of its common stock. All shares of common stock to be sold in the proposed offering are to be sold by Palvella. The proposed offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or the actual size or terms of the proposed offering.This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03160","BK4585","BK4588","TM","BK4604","BK4555","USA","PVLA","BK4099","BK4139"],"gpt_icon":0},{"id":"2614429744","title":"Palvella Therapeutics price target raised to $209 from $143 at JonesResearch","url":"https://stock-news.laohu8.com/highlight/detail?id=2614429744","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614429744?lang=en_us&edition=fundamental","pubTime":"2026-02-25 02:55","pubTimestamp":1771959317,"startTime":"0","endTime":"0","summary":"JonesResearch analyst Catherine Novack raised the firm’s price target on Palvella Therapeutics (PVLA) to $209 from $143 and keeps a Buy rating on t...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/palvella-therapeutics-price-target-raised-to-209-from-143-at-jonesresearch-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/palvella-therapeutics-price-target-raised-to-209-from-143-at-jonesresearch-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PVLA"],"gpt_icon":0},{"id":"2614374481","title":"Palvella Therapeutics Is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2614374481","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614374481?lang=en_us&edition=fundamental","pubTime":"2026-02-25 02:21","pubTimestamp":1771957260,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/PVLA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 24, 2026 13:21 ET (18:21 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PVLA"],"gpt_icon":0},{"id":"2613745858","title":"BUZZ-U.S. STOCKS ON THE MOVE-Henry Schein, Domino's Pizza, FactSet","url":"https://stock-news.laohu8.com/highlight/detail?id=2613745858","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613745858?lang=en_us&edition=fundamental","pubTime":"2026-02-24 23:55","pubTimestamp":1771948559,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Henry Schein, Domino's Pizza, FactSetEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newslett","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260224:nL6N3ZK170:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EXPD","VIR","CLVT","AMYY","ELIS","HMYY","ALUR","BOOM","ED","PVLA","FGL","OWL","KEYS","HSIC","SEG","ANPA","ELAN","NRG","AU","ROAD","TNC","ITRI","LRMR","CNP","KTOS","OKE","PPL","DPZ","WHR","HIMZ","TARA","FRPT","AWI","FDS","THR","NEMG","AMDD","HD","AES","KDP","SHLS","CVS"],"gpt_icon":1},{"id":"2613431377","title":"Palvella Therapeutics Up Over 34%, on Track for Highest Close Since March 2023 -- Data Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2613431377","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613431377?lang=en_us&edition=fundamental","pubTime":"2026-02-24 23:33","pubTimestamp":1771947180,"startTime":"0","endTime":"0","summary":"Palvella Therapeutics, Inc.  is currently at $117.90, up $30.06 or 34.22%. --Would be highest close since March 28, 2023, when it closed at $118.40. --On pace for largest percent increase since July 24, 2024, when it rose 88.6%. --Currently up four consecutive days; up 48.12% over this period. --Longest winning streak since Dec. 8, 2025, when it rose for four straight trading days. --Up 53.74% month-to-date; on pace for best month since July 2025, when it rose 62.29%. --Down 84.4% from its all-time closing high of $756.00 on Feb. 13, 2018. --Up 510.56% from 52 weeks ago , when it closed at $19.31. --Up 527.13% from its 52-week closing low of $18.80 on Feb. 26, 2025. --Traded as high as $127.69; highest intraday level since Feb. 21, 2023, when it hit $129.79","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PVLA","BK4139"],"gpt_icon":0},{"id":"2613087748","title":"Palvella Therapeutics price target raised to $255 from $200 at H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2613087748","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613087748?lang=en_us&edition=fundamental","pubTime":"2026-02-24 23:10","pubTimestamp":1771945840,"startTime":"0","endTime":"0","summary":"H.C. Wainwright raised the firm’s price target on Palvella Therapeutics (PVLA) to $255 from $200 and keeps a Buy rating on the shares. Phase 3 SELV...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/palvella-therapeutics-price-target-raised-to-255-from-200-at-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/palvella-therapeutics-price-target-raised-to-255-from-200-at-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PVLA"],"gpt_icon":0},{"id":"2613748438","title":"Palvella Therapeutics Inc. : H.c. Wainwright Raises Target Price to $255 From $200","url":"https://stock-news.laohu8.com/highlight/detail?id=2613748438","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613748438?lang=en_us&edition=fundamental","pubTime":"2026-02-24 23:09","pubTimestamp":1771945758,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260224:nAZN4SI14W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PVLA","BK4139"],"gpt_icon":0},{"id":"2613179777","title":"BUZZ-U.S. STOCKS ON THE MOVE-Advanced Micro Devices, Constellation Energy, NRG Energy","url":"https://stock-news.laohu8.com/highlight/detail?id=2613179777","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613179777?lang=en_us&edition=fundamental","pubTime":"2026-02-24 22:12","pubTimestamp":1771942333,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Advanced Micro Devices, Constellation Energy, NRG EnergyEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260224:nL6N3ZK0O3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HMYY","HIMY","OWL","AWI","KTUP","PPL","WHR","AMDD","NEMG","BEG","CEG","THR","AMDU","AMUU","ELIL","RJF","GPC","AMDG","BEX","KDP","DAMD","KEYS","LLYZ","NWMX","AMYY","KTOS","AMDW","NRG","AMD","AU","ELIS","HIYY","LRMR","HD","ROAD","AMDY","VIR","PVLA","CEGX","AES","FRPT","LLYX","BEZ","HIMZ"],"gpt_icon":1},{"id":"2613371413","title":"Mizuho Adjusts Price Target on Palvella Therapeutics to $250 From $205, Maintains Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2613371413","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613371413?lang=en_us&edition=fundamental","pubTime":"2026-02-24 21:24","pubTimestamp":1771939490,"startTime":"0","endTime":"0","summary":"Palvella Therapeutics (PVLA) has an average rating of buy and mean price target of $191.94, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from ma","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PVLA","MFG"],"gpt_icon":0},{"id":"2613719047","title":"Palvella Therapeutics Shares Jump 23% Premarket After Co's Skin Disease Drug Meets Late-Stage Trial Goal","url":"https://stock-news.laohu8.com/highlight/detail?id=2613719047","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613719047?lang=en_us&edition=fundamental","pubTime":"2026-02-24 20:53","pubTimestamp":1771937582,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260224:nFWN3ZK0IX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PVLA","BK4139"],"gpt_icon":0},{"id":"2613271978","title":"BUZZ-Palvella jumps after rare disease treatment shows improvement in late-stage study","url":"https://stock-news.laohu8.com/highlight/detail?id=2613271978","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613271978?lang=en_us&edition=fundamental","pubTime":"2026-02-24 20:49","pubTimestamp":1771937366,"startTime":"0","endTime":"0","summary":"BUZZ-Palvella jumps after rare disease treatment shows improvement in late-stage study** Shares of drug developer Palvella Therapeutics PVLA.O jump 28.1% to $112 premarket** Co says its experimental topical treatment for patients with a type of rare skin and soft tissue disease met main goal in a late-stage study** Co was testing its experimental therapy, Qtorin rapamycin, to treat microcystic lymphatic malformations ** MLMs are rare congenital conditions characterized by clusters of small, fluid-filled cysts in the lymphatic system, often leading to swelling and discomfort** The therapy showed statistically significant improvement in symptoms on the 7-point scale after 24 weeks, with an average gain of +2.13 points** \"We see today's result as a best-case scenario win, and would be buying into anticipated strength this morning. We believe Palvella shares remain substantially undervalued for the total market opportunity across Qtorin indications\" - Oppenheimer** Palvella plans to submit","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260224:nL4N3ZK14R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PVLA","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":8,"pageCount":2,"totalSize":150,"code":"91000000","status":"200"}]}}